Syndax Pharmaceuticals, Inc. (SNDX)
19.42
0.00 (0.00%)
USD |
NASDAQ |
May 19, 14:00
Syndax Pharmaceuticals Research and Development Expense (Quarterly) : 58.84M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 74.21M |
| Vera Therapeutics, Inc. | 85.87M |
| Biogen, Inc. | 471.10M |
| Amgen, Inc. | 1.719B |
| Ardelyx, Inc. | 19.27M |